Cargando…
Plasma Interleukin-37 is Elevated in Acute Ischemic Stroke Patients and Probably Associated With 3-month Functional Prognosis
BACKGROUND: Interleukin-37 is a novel cytokine emerging as a natural suppressor of inflammatory responses. Inflammation and the immune response play important roles in acute ischemic stroke. This study aimed at evaluating the plasma levels and the association with 3-month outcomes of interleukin-37...
Autores principales: | Zhang, Feng, Zhu, Tianrui, Li, Heng, He, Yi, Zhang, Yuanyuan, Huang, Nana, Zhang, Guitao, Li, Yanshuang, Chang, Dujuan, Li, Xiaohong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414924/ https://www.ncbi.nlm.nih.gov/pubmed/32801675 http://dx.doi.org/10.2147/CIA.S230186 |
Ejemplares similares
-
Long-term icariin treatment ameliorates cognitive deficits via CD4(+) T cell-mediated immuno-inflammatory responses in APP/PS1 mice
por: Zhu, Tianrui, et al.
Publicado: (2019) -
Independent Predictive Value of Elevated YKL-40 in Ischemic Stroke Prognosis: Findings from a Nationwide Stroke Registry
por: Qin, Haiqiang, et al.
Publicado: (2023) -
Serum Interleukin-37 Increases in Patients after Ischemic Stroke and Is Associated with Stroke Recurrence
por: Zhang, Ying, et al.
Publicado: (2021) -
Elevated levels of interleukin‐35 and interleukin‐37 in adult patients with obstructive sleep apnea
por: Chen, Bi, et al.
Publicado: (2021) -
Elevated Levels of Cerebrospinal Fluid and Plasma Interleukin-37 in Patients with Guillain-Barré Syndrome
por: Li, Cong, et al.
Publicado: (2013)